Correlation Between United Therapeutics and Crispr Therapeutics
Can any of the company-specific risk be diversified away by investing in both United Therapeutics and Crispr Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining United Therapeutics and Crispr Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between United Therapeutics and Crispr Therapeutics AG, you can compare the effects of market volatilities on United Therapeutics and Crispr Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in United Therapeutics with a short position of Crispr Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of United Therapeutics and Crispr Therapeutics.
Diversification Opportunities for United Therapeutics and Crispr Therapeutics
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between United and Crispr is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding United Therapeutics and Crispr Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crispr Therapeutics and United Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on United Therapeutics are associated (or correlated) with Crispr Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crispr Therapeutics has no effect on the direction of United Therapeutics i.e., United Therapeutics and Crispr Therapeutics go up and down completely randomly.
Pair Corralation between United Therapeutics and Crispr Therapeutics
Given the investment horizon of 90 days United Therapeutics is expected to generate 0.59 times more return on investment than Crispr Therapeutics. However, United Therapeutics is 1.7 times less risky than Crispr Therapeutics. It trades about 0.12 of its potential returns per unit of risk. Crispr Therapeutics AG is currently generating about 0.04 per unit of risk. If you would invest 34,971 in United Therapeutics on August 27, 2024 and sell it today you would earn a total of 1,895 from holding United Therapeutics or generate 5.42% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
United Therapeutics vs. Crispr Therapeutics AG
Performance |
| Timeline |
| United Therapeutics |
| Crispr Therapeutics |
United Therapeutics and Crispr Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with United Therapeutics and Crispr Therapeutics
The main advantage of trading using opposite United Therapeutics and Crispr Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if United Therapeutics position performs unexpectedly, Crispr Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crispr Therapeutics will offset losses from the drop in Crispr Therapeutics' long position.| United Therapeutics vs. Incyte | United Therapeutics vs. Alnylam Pharmaceuticals | United Therapeutics vs. Ultragenyx | United Therapeutics vs. Apellis Pharmaceuticals |
| Crispr Therapeutics vs. Beam Therapeutics | Crispr Therapeutics vs. Editas Medicine | Crispr Therapeutics vs. Caribou Biosciences | Crispr Therapeutics vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |